abstract |
A composition comprises formononetin and one or more isoflavones selected from biochanin, genistein and daidzen, in a ratio of formononetin to isoflavone of 15:1 to 2:1 optionally in association with one or more carriers, excipients, auxiliaries and/or diluents. The composition is useful in the prevention and/or treatment of cardiovascular diseases, the beneficial alteration of blood lipoprotein levels, to reduce the risk of coronary heart disease, to reduce the risk of arteriosclerosis, in the beneficial alteration or maintenance of bone density, and in the prevention and/or treatment of osteoporosis and bone factures. Preferably the formononetin and biochanin comprise an extract of chickpea or clover. |